| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating income | 20,928 | 15,291 | 4,417 | 19,803 |
| Interest expense | 2,650 | 2,711 | 2,602 | 3,108 |
| Income before income taxes | 18,278 | 12,580 | 1,815 | 16,695 |
| Income tax expense | 3,754 | 1,911 | 1,746 | 4,691 |
| Net income | 14,524 | 10,669 | 69 | 12,004 |
| Net income attributable to non-controlling interest | 285 | 33 | 223 | 259 |
| Net income attributable to core laboratories inc | 14,239 | 10,636 | -154 | 11,745 |
| Basic earnings (loss) per share attributable to core laboratories n.v | 0.31 | 0.23 | 0 | 0.25 |
| Diluted earnings per share attributable to core laboratories inc | 0.3 | 0.22 | 0 | 0.25 |
| Weighted average number of shares outstanding, basic | 46,263,000 | 46,632,000 | 46,773,000 | 46,922,000 |
| Weighted average number of shares outstanding, diluted | 47,078,000 | 47,364,000 | 46,773,000 | 47,820,000 |
Core Laboratories Inc. DE (CLB)
Core Laboratories Inc. DE (CLB)